Investor Ugwumba Chidozie
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Ugwumba Chidozie . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-10-02 13G/A VGG8959N1069 / Tottenham Acquisition I Limited 28,018,908 2,249,661
2023-12-13 13G FNCH / Finch Therapeutics Group, Inc. 3,500,000 160,366
2023-09-11 13G VGG8959N1069 / Tottenham Acquisition I Limited 5,518,908 28,018,908
2023-02-13 13D/A VGG8959N1069 / Tottenham Acquisition I Limited 4,616,854 5,518,908
2023-02-13 13G/A PHGE / BiomX Inc. 2,997,025 922,800
2022-11-14 13G/A PHGE / BiomX Inc. 5,512,846 2,997,025
2022-05-10 13G SRZN / Surrozen, Inc. 1,964,082 1,964,082
2022-02-14 13G PHGE / BiomX Inc. 5,512,846
2022-02-14 13G TNYA / Tenaya Therapeutics, Inc. 2,642,285
2022-02-14 13G FNCH / Finch Therapeutics Group, Inc. 3,500,000
2022-02-14 13D VGG8959N1069 / Tottenham Acquisition I Limited 4,616,854